Search

Your search keyword '"Popplewell A"' showing total 4,645 results
Start Over Author "Popplewell A"
4,645 results on '"Popplewell A"'

52. Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study

Author

Kwak, Larry W., Sancho, Juan-Manuel, Cho, Seok-Goo, Nakazawa, Hideyuki, Suzumiya, Junji, Tumyan, Gayane, Kim, Jin Seok, Menne, Tobias, Mariz, José, Ilyin, Nikolai, Jurczak, Wojciech, Lopez Martinez, Aurelio, Samoilova, Olga, Zhavrid, Edvard, Yañez Ruiz, Eduardo, Trneny, Marek, Popplewell, Leslie, Ogura, Michinori, Kim, Won-Seog, Lee, Sang Joon, Kim, Sung Hyun, Ahn, Keum Young, and Buske, Christian

Published
2022
Full Text
View/download PDF

53. Documenting the Recovery of Vascular Services in European Centres Following the Initial COVID-19 Pandemic Peak: Results from a Multicentre Collaborative Study

Author

Ruffino, Maria Antonella, Chan, Sharon, Coughlin, Patrick, Awopetu, Ayoola, Stather, Philip, Lane, Tristan, Theodosiou, Dimitrios, Ahmed, Mohamed Abozeid, Vasudevan, Thodur, Ibrahim, Mohammed, Al Maadany, Faraj, Eljareh, Mohamed, Alkhafeefi, Fatimah Saad, Coscas, Raphael, Ünal, Ertekin Utku, Pulli, Raffaele, Zacà, Sergio, Angiletta, Domenico, Kotsis, Thomas, Moawad, Magdy, Tozzi, Matteo, Patelis, Nikolaos, Lazaris, Andreas M., Chuen, Jason, Croo, Alexander, Tsolaki, Elpiniki, Zenunaj, Gladiol, Kamal, Dhafer, Tolba, Mahmoud MH., Maresch, Martin, Khetarpaul, Vipul, Mills, Joseph, Gangwani, Gaurav, Elahwal, Mohamed, Khalil, Rana, Azab, Mohammed A., Mahomed, Anver, Whiston, Richard, Contractor, Ummul, Esposito, Davide, Pratesi, Carlo, Giacomelli, Elena, Troncoso, Martín Veras, Elkouri, Stephane, Johansson, Flavia Gentile, Dodos, Ilias, Benezit, Marie, Vidoedo, José, Rocha-Neves, João, Pereira-Neves, António Henrique, Dias-Neto, Marina Felicidade, Campos Jácome, Ana Filipa, Loureiro, Luis, Silva, Ivone, Garza-Herrera, Rodrigo, Canata, Victor, Bezard, Charlotte, Bowser, Kathryn, Tobar, Jorge Felipe, Vera, Carlos Gomez, Parra, Carolina Salinas, Lopez, Eugenia, Serra, Yvis Gadelha, Varela, Juan, Rubio, Vanessa, Victoria, Gerardo, Johnson, Adam, O’Banion, Leigh Ann, Makar, Ragai, Tantawy, Tamer Ghatwary, Storck, Martin, Jongkind, Vincent, falah, Orwa, McBride, Olivia, Isik, Arda, Papaioannou, Athanasios, Ocke Reis, Paulo Eduardo, Bracale, Umberto Marcello, Atkins, Ellie, Tinelli, Giovanni, Scott, Emma, Wales, Lucy, Sivaharan, Ashwin, Priona, Georgia, Nesbitt, Craig, Grainger, Tabitha, Shelmerdine, Lauren, Chong, Patrick, Bajwa, Adnan, Arwynck, Luke, Hadjievangelou, Nancy, Elbasty, Ahmed, Rubio, Oscar, Ricardo, Michael, Ulloa, Jorge H., Tarazona, Marcos, Pabon, Manuel, Pitoulias, Georgios, Corless, Kevin, Ioannidis, Orestis, Friedrich, Oliver, Van Herzeele, Isabelle, Vijaynagar, Badri, Cohnert, Tina, Bell, Rachel, Moore, Hayley, Saha, Prakash, Gifford, Edward, Laine, Matti, Barkat, Adel, Karkos, Christos, Binti Safri, Lenny Suryani, Buitron, Gabriel, Del Castillo, Javier, Carrera, Paul, Salinas, Nilson, Biagioni, Rodrigo Bruno, Benites, Sergio, Mafla, César Andrés, Pian, Putera Mas, Albino, Pereira, Serrano, Ernesto, Marin, Andres, González, Marco, Foreroga, Marsha, Russo, Alejandro, Reyes, Andrés, Guglielmone, Daniel, Grillo, Lorena, Flumignan, Ronald, Palones, Francisco Gomez, Silveira, Pierre Galvagni, Ramely, Rosnelifaizur Bin, Edeiken, Sara, Chetter, Ian, Green, Lucy, Sudarsanam, Abhilash, Lyons, Oliver, Lemmon, Gary, Neville, Richard, Castelli, Mariano, Hinojosa, Carlos A., Carvajal, Rubén Rodríguez, Rivera, Aksim, Wong, Peng, Drudi, Laura, Perkins, Jeremy, Sieunarine, Kishore, Attia, Doaa, Atef, Mahmoud, Eftychios, Lostoridis, Weaver, Fred, Ren, Leong Chuo, Alomari, Mohannad, Jamjoom, Reda, Aljarrah, Qusai, Abbas, Ayman, Alomran, Faris, Kumar, Ambrish, Altoijri, Abdulmajeed, ElSanhoury, Kareem T., Alhumaid, Ahmed, Fekry, Tamer, Sekhar, Raghuram, Theodoridis, Panagiotis, Panagiotis, Theodoridis, Roditis, Konstantinos, Tsiantoula, Paraskevi, Antoniou, Afroditi, Soler, Raphael, Hasemaki, Natasha, Baili, Efstratia, Mpaili, Eustratia, Huasen, Bella, Wallace, Tom, Duncan, Andrew, Metcalfe, Matthew, Mannoia, Kristyn, Bechara, Carlos F., Tsilimparis, Nikolaos, Aranson, Nathan, Riding, David, Palena, Mariano, McDonnell, Ciarán, Mouawad, Nicolas J., Banegas, Shonda, Rossi, Peter, Oshodi, Taohid, Diaz, Rodney, Afifi, Rana, Dindyal, Shiva, Thapar, Ankur, Kordzadeh, Ali, Pullas, Gonzalo, Lin, Stephanie, Davies, Chris, Darvall, Katy, Kodama, Akio, Gooneratne, Thushan, Gunawansa, Nalaka, Munoz, Alberto, Jie, Ng Jun, Bradley, Nicholas, Al-Jundi, Wissam, Meyer, Felicity, Lee, Cheong, Malina, Martin, Renton, Sophie, Lui, Dennis, Batchelder, Andrew, Oszkinis, Grzegorz, Freyrie, Antonio, Giordano, Jacopo, Saratzis, Nikolaos, Tigkiropoulos, Konstantinos, Kyriakos, Stavridis, Popov, Guriy, Cheema, Muhammad Usman, Lapolla, Pierfrancesco, Ling Patricia, Yih Chun, Ennab, Raed, Ullery, Brant W., Pasenidou, Ketino, Tam, Jacky, Sidel, Gabriel, Jayaprakash, Vivek Vardhan, Bennett, Lisa, Hardy, Simon, Davies, Emma, Baker, Sara, Wijesinghe, Lasantha, Tam, Adam, McCune, Ken, Chana, Manik, Lowe, Chris, Goh, Aaron, Powezka, Katarzyna, Kyrou, Ioanna, Altaf, Nishath, Harkin, Denis, Travers, Hannah, Cragg, James, sharif, Atif, Akhtar, Tasleem, Chávez, José Antonio, Ordonez, Claudia, Mazzurco, Martin, Choke, Edward, Asghar, Imran, Summerour, Virginia, Dunlop, Paul, Morley, Rachel, Hardy, Thomas, Bevis, Paul, Cuff, Robert, Stavroulakis, Konstantinos, Beropoulis, Efthymios, Argyriou, Angeliki, Loftus, Ian, Azhar, Bilal, Sheth, Sharvil, Usai, Marco Virgilio, Choudhry, Asad, Nicole, Kira, Boyle, Emily, Joyce, Doireann, Abdelaty Hassan, Mohammed Hassan, Saltiel, Alberto, Frahm-Jensen, Gert, Antoniou, George, Elhadi, Muhammed, Kimyaghalam, Ali, Malgor, Rafael, O'Banion, Leigh Ann, Telve, Diego, Isaak, Andrej, Schmidli, Jürg, McKevitt, Kevin, Siddiqui, Tam, Asciutto, Giuseppe, Floros, Nikolaos, Papadopoulos, George, Kafetzakis, Alexandros, Koutsias, Stylianos G., Nana, Petroula, Giannoukas, Athanasios, Kakkos, Stavros, Moulakakis, Konstantinos G., Shafique, Natasha, Jawien, Arkadiusz, Popplewell, Matthew, Imray, Chris, Abayasekara, Kumar, Rowlands, Timothy, Kuhan, Ganesh, Rajagopalan, Sriram, Jaipersad, Anthony, Sadia, Uzma, Kobe, Isaac, Mittapalli, Devender, Enemosah, Ibrahim, Behrendt, Christian-Alexander, Beck, Adam, Almudhafer, Muayyad, Ancetti, Stefano, Jacobs, Donald, Jayakumar, Priya, Malekpour, Fatemeh, Shalhub, Sherene, Keldiyorov, Boboyor, Simon, Meryl, Khashram, Manar, Rich, Nicole, Shepherd, Amanda, Meecham, Lewis, Doherty, Daniel, and Benson, Ruth A.

Published
2022
Full Text
View/download PDF

54. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Author

Fowler, Nathan Hale, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin, Kolstad, Arne, Butler, Jason, Ghosh, Monalisa, Popplewell, Leslie, Chavez, Julio C., Bachy, Emmanuel, Kato, Koji, Harigae, Hideo, Kersten, Marie José, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Pérez-Simón, José Antonio, Chen, Andy I., Nastoupil, Loretta J., von Tresckow, Bastian, Ferreri, Andrés José María, Teshima, Takanori, Patten, Piers E. M., McGuirk, Joseph P., Petzer, Andreas L., Offner, Fritz, Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram, Zia, Aiesha, Awasthi, Rakesh, Masood, Aisha, Anak, Oezlem, Schuster, Stephen J., and Thieblemont, Catherine

Published
2022
Full Text
View/download PDF

55. Documenting the Recovery of Vascular Services in European Centres Following the Initial COVID-19 Pandemic Peak: Results from a Multicentre Collaborative Study

Author

Ruth A. Benson, Maria Antonella Ruffino, Sharon Chan, Patrick Coughlin, Ayoola Awopetu, Philip Stather, Tristan Lane, Dimitrios Theodosiou, Mohamed Abozeid Ahmed, Thodur Vasudevan, Mohammed Ibrahim, Faraj Al Maadany, Mohamed Eljareh, Fatimah Saad Alkhafeefi, Raphael Coscas, Ertekin Utku Ünal, Raffaele Pulli, Sergio Zacà, Domenico Angiletta, Thomas Kotsis, Magdy Moawad, Matteo Tozzi, Nikolaos Patelis, Andreas M. Lazaris, Jason Chuen, Alexander Croo, Elpiniki Tsolaki, Gladiol Zenunaj, Dhafer Kamal, Mahmoud MH. Tolba, Martin Maresch, Vipul Khetarpaul, Joseph Mills, Gaurav Gangwani, Mohamed Elahwal, Rana Khalil, Mohammed A. Azab, Anver Mahomed, Richard Whiston, Ummul Contractor, Davide Esposito, Carlo Pratesi, Elena Giacomelli, Martín Veras Troncoso, Stephane Elkouri, Flavia Gentile Johansson, Ilias Dodos, Marie Benezit, José Vidoedo, João Rocha-Neves, António Henrique Pereira-Neves, Marina Felicidade Dias-Neto, Ana Filipa Campos Jácome, Luis Loureiro, Ivone Silva, Rodrigo Garza-Herrera, Victor Canata, Charlotte Bezard, Kathryn Bowser, Jorge Felipe Tobar, Carlos Gomez Vera, Carolina Salinas Parra, Eugenia Lopez, Yvis Gadelha Serra, Juan Varela, Vanessa Rubio, Gerardo Victoria, Adam Johnson, Leigh Ann O’Banion, Ragai Makar, Tamer Ghatwary Tantawy, Martin Storck, Vincent Jongkind, Orwa falah, Olivia McBride, Arda Isik, Athanasios Papaioannou, Paulo Eduardo Ocke Reis, Umberto Marcello Bracale, Ellie Atkins, Giovanni Tinelli, Emma Scott, Lucy Wales, Ashwin Sivaharan, Georgia Priona, Craig Nesbitt, Tabitha Grainger, Lauren Shelmerdine, Patrick Chong, Adnan Bajwa, Luke Arwynck, Nancy Hadjievangelou, Ahmed Elbasty, Oscar Rubio, Michael Ricardo, Jorge H. Ulloa, Marcos Tarazona, Manuel Pabon, Georgios Pitoulias, Kevin Corless, Orestis Ioannidis, Oliver Friedrich, Isabelle Van Herzeele, Badri Vijaynagar, Tina Cohnert, Rachel Bell, Hayley Moore, Prakash Saha, Edward Gifford, Matti Laine, Adel Barkat, Christos Karkos, Lenny Suryani Binti Safri, Gabriel Buitron, Javier Del Castillo, Paul Carrera, Nilson Salinas, Rodrigo Bruno Biagioni, Sergio Benites, César Andrés Mafla, Putera Mas Pian, Pereira Albino, Ernesto Serrano, Andres Marin, Marco González, Marsha Foreroga, Alejandro Russo, Andrés Reyes, Daniel Guglielmone, Lorena Grillo, Ronald Flumignan, Francisco Gomez Palones, Pierre Galvagni Silveira, Rosnelifaizur Bin Ramely, Sara Edeiken, Ian Chetter, Lucy Green, Abhilash Sudarsanam, Oliver Lyons, Gary Lemmon, Richard Neville, Mariano Castelli, Carlos A. Hinojosa, Rubén Rodríguez Carvajal, Aksim Rivera, Peng Wong, Laura Drudi, Jeremy Perkins, Kishore Sieunarine, Doaa Attia, Mahmoud Atef, Lostoridis Eftychios, Fred Weaver, Leong Chuo Ren, Mohannad Alomari, Reda Jamjoom, Qusai Aljarrah, Ayman Abbas, Faris Alomran, Ambrish Kumar, Abdulmajeed Altoijri, Kareem T. ElSanhoury, Ahmed Alhumaid, Tamer Fekry, Raghuram Sekhar, Panagiotis Theodoridis, Theodoridis Panagiotis, Konstantinos Roditis, Paraskevi Tsiantoula, Afroditi Antoniou, Raphael Soler, Natasha Hasemaki, Efstratia Baili, Eustratia Mpaili, Bella Huasen, Tom Wallace, Andrew Duncan, Matthew Metcalfe, Kristyn Mannoia, Carlos F. Bechara, Nikolaos Tsilimparis, Nathan Aranson, David Riding, Mariano Palena, Ciarán McDonnell, Nicolas J. Mouawad, Shonda Banegas, Peter Rossi, Taohid Oshodi, Rodney Diaz, Rana Afifi, Shiva Dindyal, Ankur Thapar, Ali Kordzadeh, Gonzalo Pullas, Stephanie Lin, Chris Davies, Katy Darvall, Akio Kodama, Thushan Gooneratne, Nalaka Gunawansa, Alberto Munoz, Ng Jun Jie, Nicholas Bradley, Wissam Al-Jundi, Felicity Meyer, Cheong Lee, Martin Malina, Sophie Renton, Dennis Lui, Andrew Batchelder, Grzegorz Oszkinis, Antonio Freyrie, Jacopo Giordano, Nikolaos Saratzis, Konstantinos Tigkiropoulos, Stavridis Kyriakos, Guriy Popov, Muhammad Usman Cheema, Pierfrancesco Lapolla, Yih Chun Ling Patricia, Raed Ennab, Brant W. Ullery, Ketino Pasenidou, Jacky Tam, Gabriel Sidel, Vivek Vardhan Jayaprakash, Lisa Bennett, Simon Hardy, Emma Davies, Sara Baker, Lasantha Wijesinghe, Adam Tam, Ken McCune, Manik Chana, Chris Lowe, Aaron Goh, Katarzyna Powezka, Ioanna Kyrou, Nishath Altaf, Denis Harkin, Hannah Travers, James Cragg, Atif sharif, Tasleem Akhtar, José Antonio Chávez, Claudia Ordonez, Martin Mazzurco, Edward Choke, Imran Asghar, Virginia Summerour, Paul Dunlop, Rachel Morley, Thomas Hardy, Paul Bevis, Robert Cuff, Konstantinos Stavroulakis, Efthymios Beropoulis, Angeliki Argyriou, Ian Loftus, Bilal Azhar, Sharvil Sheth, Marco Virgilio Usai, Asad Choudhry, Kira Nicole, Emily Boyle, Doireann Joyce, Mohammed Hassan Abdelaty Hassan, Alberto Saltiel, Gert Frahm-Jensen, George Antoniou, Muhammed Elhadi, Ali Kimyaghalam, Rafael Malgor, Leigh Ann O'Banion, Diego Telve, Andrej Isaak, Jürg Schmidli, Kevin McKevitt, Tam Siddiqui, Giuseppe Asciutto, Nikolaos Floros, George Papadopoulos, Alexandros Kafetzakis, Stylianos G. Koutsias, Petroula Nana, Athanasios Giannoukas, Stavros Kakkos, Konstantinos G. Moulakakis, Natasha Shafique, Arkadiusz Jawien, Matthew Popplewell, Chris Imray, Kumar Abayasekara, Timothy Rowlands, Ganesh Kuhan, Sriram Rajagopalan, Anthony Jaipersad, Uzma Sadia, Isaac Kobe, Devender Mittapalli, Ibrahim Enemosah, Christian-Alexander Behrendt, Adam Beck, Muayyad Almudhafer, Stefano Ancetti, Donald Jacobs, Priya Jayakumar, Fatemeh Malekpour, Sherene Shalhub, Boboyor Keldiyorov, Meryl Simon, Manar Khashram, Nicole Rich, Amanda Shepherd, Lewis Meecham, and Daniel Doherty

Subjects
AAA, COVID-19, PAD, Survey, Vascular surgery, Diseases of the circulatory (Cardiovascular) system, RC666-701, Surgery, RD1-811
Abstract

Objective: To document the recovery of vascular services in Europe following the first COVID-19 pandemic peak. Methods: An online structured vascular service survey with repeated data entry between 23 March and 9 August 2020 was carried out. Unit level data were collected using repeated questionnaires addressing modifications to vascular services during the first peak (March – May 2020, “period 1”), and then again between May and June (“period 2”) and June and July 2020 (“period 3”). The duration of each period was similar. From 2 June, as reductions in cases began to be reported, centres were first asked if they were in a region still affected by rising cases, or if they had passed the peak of the first wave. These centres were asked additional questions about adaptations made to their standard pathways to permit elective surgery to resume. Results: The impact of the pandemic continued to be felt well after countries’ first peak was thought to have passed in 2020. Aneurysm screening had not returned to normal in 21.7% of centres. Carotid surgery was still offered on a case by case basis in 33.8% of centres, and only 52.9% of centres had returned to their normal aneurysm threshold for surgery. Half of centres (49.4%) believed their management of lower limb ischaemia continued to be negatively affected by the pandemic. Reduced operating theatre capacity continued in 45.5% of centres. Twenty per cent of responding centres documented a backlog of at least 20 aortic repairs. At least one negative swab and 14 days of isolation were the most common strategies used for permitting safe elective surgery to recommence. Conclusion: Centres reported a broad return of services approaching pre-pandemic “normal” by July 2020. Many introduced protocols to manage peri-operative COVID-19 risk. Backlogs in cases were reported for all major vascular surgeries.

Published
2022
Full Text
View/download PDF

57. Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Author

Aldoss, Ibrahim, primary, Zhang, Jianying, additional, Robbins, Marjorie, additional, Song, Joo, additional, Al Malki, Monzr M., additional, Otoukesh, Salman, additional, Sandhu, Karamjeet, additional, Agrawal, Vaibhav, additional, Herrera, Alex F., additional, Popplewell, Leslie L., additional, Ghoda, Lucy, additional, Stein, Anthony, additional, Marcucci, Guido, additional, Forman, Stephen, additional, and Pullarkat, Vinod, additional

Published
2024
Full Text
View/download PDF

61. Creating spaces for peace? : civil society, political space, and peacebuilding in post-war Burundi

Author

Popplewell, Rowan, Daley, Patricia, and Hayman, Rachel

Subjects
320.1, Political geography, Burundi, Peacebuilding, Africa, Civil society, Political space
Abstract

This thesis examines civil society, political space, and peacebuilding in post-war Burundi by critically engaging with international discourses and considering the extent to which they reflect the experiences and perspectives of activists on the ground. It is based on qualitative research with civil society groups and the individuals that work for them in Burundi. Fieldwork took place over five months between July 2014 and April 2015. This was a period of crisis in which civil society faced mounting restrictions, from the introduction of legislation that banned public gatherings, to the harassment and intimidation of prominent activists. The thesis analyses the extent to which civil society groups were able to navigate these constraints to create and maintain spaces for peace that transform dominant social norms which produce violence and repression. It also considers the factors that frustrated these efforts, from the sustained influence of past violence and trauma, to the climate of fear and uncertainty that emerged following the 2015 elections, and the divisive elite politics that continues to disrupt everyday peace in Burundi. It finds that emerging policy discourses on political space fail to engage with the historical, political, and discursive nature of government restrictions in Burundi, and the temporal and relational dimensions of violence, especially the ways in which it shapes the everyday lives of activists and their ability to challenge the institutions and structures within which violence is reproduced. The research situates these experiences in historical context – a process that enables it to consider broader questions about the evolution of civil society and the extent to which it becomes embedded in post-conflict contexts once international funding and attention decreases and external peacebuilding activities conclude. Civil society groups in Burundi received significant support from the international community in the post-war years, yet increasing restrictions suggest that the Burundian government has not accepted the presence of certain organisations which it views as a threat to its political authority and legitimacy. This leads the thesis to argue that curbs on civil society should be seen as part of a broader pattern of resistance to international peacebuilding in Burundi.

Published
2017

63. Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD)

Author

Pradeep Harish, Alberto Malerba, Rosemarie H. M. J. M. Kroon, Milad Shademan, Baziel van Engelan, Vered Raz, Linda Popplewell, and Stuart G. Snowden

Subjects
biomarker, metabolomics, LC-MS, random forest, oculopharyngeal muscular dystrophy, Microbiology, QR1-502
Abstract

The identification of metabolomic biomarkers relies on the analysis of large cohorts of patients compared to healthy controls followed by the validation of markers in an independent sample set. Indeed, circulating biomarkers should be causally linked to pathology to ensure that changes in the marker precede changes in the disease. However, this approach becomes unfeasible in rare diseases due to the paucity of samples, necessitating the development of new methods for biomarker identification. The present study describes a novel approach that combines samples from both mouse models and human patients to identify biomarkers of OPMD. We initially identified a pathology-specific metabolic fingerprint in murine dystrophic muscle. This metabolic fingerprint was then translated into (paired) murine serum samples and then to human plasma samples. This study identified a panel of nine candidate biomarkers that could predict muscle pathology with a sensitivity of 74.3% and specificity of 100% in a random forest model. These findings demonstrate that the proposed approach can identify biomarkers with good predictive performance and a higher degree of confidence in their relevance to pathology than markers identified in a small cohort of human samples alone. Therefore, this approach has a high potential utility for identifying circulating biomarkers in rare diseases.

Published
2023
Full Text
View/download PDF

65. Targeted Therapeutics for Rare Disorders

Author

Keeling, Kim M., primary, Leier, Andre, additional, Bedwell, David M., additional, Chen, Ann T., additional, Kesterson, Robert A., additional, Marquez Lago, Tatiana T., additional, Müller, Ulrich F., additional, Zhou, Jiangbing, additional, Popplewell, Linda, additional, and Wallis, Deeann, additional

Published
2022
Full Text
View/download PDF

66. An ode to Sports Illustrated

Author

Popplewell, Brett

Subjects
Sports Illustrated (Periodical) -- Licensing, certification and accreditation, Periodical publishing -- Human resource management, Company personnel management, General interest, News, opinion and commentary
Abstract

Byline: BRETT POPPLEWELL Associate professor of journalism at Carleton University and the author of Outsider: An Old Man, a Mountain and the Search for a Hidden Past. His writing has [...]

Published
2024

67. An ode to Sports Illustrated and the journalism it represented

Author

Popplewell, Brett

Subjects
ESPN Inc., Cable television broadcasting industry, College teachers, Journalism
Abstract

The type of writing the magazine was once known for is becoming increasingly hard to find, Brett Popplewell is an associate professor of journalism at Carleton University and the author of Outsider: An Old Man, a Mountain and the Search for a Hidden Past . His [...]

Published
2024

68. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study

Author

Keller, Roberta L, Feng, Rui, DeMauro, Sara B, Ferkol, Thomas, Hardie, William, Rogers, Elizabeth E, Stevens, Timothy P, Voynow, Judith A, Bellamy, Scarlett L, Shaw, Pamela A, Moore, Paul E, Program, Prematurity and Respiratory Outcomes, Alexander, Barbara, Chougnet, Claire, Gratton, Tari, Greenberg, James M, Grisby, Cathy, Jobe, Alan H, Koch, Beth, McDowell, Karen, Thornton, Kelly, Bates, Pamela, Cleveland, Claudia, Hamvas, Aaron, Hoffmann, Julie, Holland, Mark R, Kemp, James, Levy, Philip T, Linneman, Laura, Sicard-Su, Jayne, Simpson, Gina, Singh, Gautam K, Warner, Barbara, Ballard, Philip L, Ballard, Roberta A, Durand, David J, Eichenwald, Eric C, Khan, Amir M, Lusk, Leslie, Merrill, Jeffrey D, Nielson, Dennis W, Asselin, Jeanette M, Balan, Samantha, Burson, Katrina, Chapin, Cheryl, Josiah-Davis, Erna, Garcia, Carmen, Horneman, Hart, Hinojosa, Rick, Johnson, Christopher, Kelley, Susan, Knowles, Karin L, Lillie, M Layne, Martin, Karen, Martin, Sarah, Arldt-McAlister, Julie, McDavid, Georgia E, Pacello, Lori, Rodgers, Shawna, Sperry, Daniel K, Aschner, Judy, Beller, Amy B, Fike, Candice, Guthrie, Scott, Hartert, Tina, Maitre, Nathalie, O'Hunt, Mark, Rogers, Theresa J, Settles, Odessa L, Steele, Steven, Summar, Marshall, Wadley, Sharon, D'Angio, Carl, Kumar, Vasanth, Mariani, Tom, Pryhuber, Gloria, Ren, Clement, Reynolds, Anne Marie, Ryan, Rita M, Scheible, Kristin, Huyck, Heidie, Lunger, Valerie, Castiglione, Shannon, Horan, Aimee, Maffet, Deanna, O'Donnell, Jane, Sacilowski, Michael, Scalise, Tanya, Werner, Elizabeth, Zayac, Jason, Bordeaux, Kim, Brown, Pam, Epping, Julia, Flattery-Walsh, Lisa, Germuga, Donna, Jenks, Nancy, Platt, Mary, Popplewell, Eileen, Prentice, Sandra, and Ciccio, Kim

Subjects
Paediatrics, Reproductive Medicine, Biomedical and Clinical Sciences, Neonatal Respiratory Distress, Clinical Trials and Supportive Activities, Preterm, Low Birth Weight and Health of the Newborn, Clinical Research, Lung, Pediatric, Infant Mortality, Perinatal Period - Conditions Originating in Perinatal Period, Respiratory, Reproductive health and childbirth, Good Health and Well Being, Bronchopulmonary Dysplasia, Cohort Studies, Female, Gestational Age, Health Surveys, Humans, Infant, Infant, Newborn, Infant, Very Low Birth Weight, Male, Morbidity, Pregnancy, Prognosis, Prospective Studies, Prematurity and Respiratory Outcomes Program, prematurity, pulmonary morbidity, wheeze, Human Movement and Sports Sciences, Paediatrics and Reproductive Medicine, Pediatrics
Abstract

OBJECTIVE:To assess the utility of clinical predictors of persistent respiratory morbidity in extremely low gestational age newborns (ELGANs). STUDY DESIGN:We enrolled ELGANs (

Published
2017

69. Anti-CD25 Radioimmunotherapy with BEAM Autologous Hematopoietic Cell Transplantation Conditioning in Hodgkin Lymphoma

Author

Herrera, Alex F., Palmer, Joycelynne, Adhikarla, Vikram, Yamauchi, Dave, Poku, Erasmus K., Bading, James, Yazaki, Paul, Dandapani, Savita, Mei, Matthew, Chen, Robert, Cao, Thai, Karras, Nicole, McTague, Pamela, Nademanee, Auayporn, Popplewell, Leslie, Sahebi, Firoozeh, Shively, John E., Simpson, Jennifer, Smith, D. Lynne, Song, Joo, Spielberger, Ricardo, Tsai, Ni-Chun, Thomas, Sandra H., Forman, Stephen J., Colcher, David, Wu, Anna M., Wong, Jeffrey, and Smith, Eileen

Published
2021
Full Text
View/download PDF

70. RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways

Author

Victoria Gudiño, Sebastian Öther-Gee Pohl, Caroline V. Billard, Patrizia Cammareri, Alfonso Bolado, Stuart Aitken, David Stevenson, Adam E. Hall, Mark Agostino, John Cassidy, Colin Nixon, Alex von Kriegsheim, Paz Freile, Linda Popplewell, George Dickson, Laura Murphy, Ann Wheeler, Malcolm Dunlop, Farhat Din, Douglas Strathdee, Owen J. Sansom, and Kevin B. Myant

Subjects
Science
Abstract

RAC1 is a downstream target of the Wnt signaling that promotes intestinal stem cell expansion and tumorigenesis. Here, the authors identify the specific splice variant RAC1B as an important mediator of colorectal tumourigenesis and a potential target for enhancing the efficacy of EGFR inhibitor treatment.

Published
2021
Full Text
View/download PDF

71. Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy

Author

Viktorija Cernisova, Ngoc Lu-Nguyen, Jessica Trundle, Shan Herath, Alberto Malerba, and Linda Popplewell

Subjects
Duchenne muscular dystrophy, muscle pathology, AAV8-microdystrophin, fibrosis, Biology (General), QH301-705.5, Chemistry, QD1-999
Abstract

Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease affecting 1:5000 newborn males. No cure is currently available, but gene addition therapy, based on the adeno-associated viral (AAV) vector-mediated delivery of microdystrophin transgenes, is currently being tested in clinical trials. The muscles of DMD boys present significant fibrotic and adipogenic tissue deposition at the time the treatment starts. The presence of fibrosis not only worsens the disease pathology, but also diminishes the efficacy of gene therapy treatments. To gain an understanding of the efficacy of AAV-based microdystrophin gene addition in a relevant, fibrotic animal model of DMD, we conducted a systemic study in juvenile D2.mdx mice using the single intravenous administration of an AAV8 system expressing a sequence-optimized murine microdystrophin, named MD1 (AAV8-MD1). We mainly focused our study on the diaphragm, a respiratory muscle that is crucial for DMD pathology and that has never been analyzed after treatment with AAV-microdystrophin in this mouse model. We provide strong evidence here that the delivery of AAV8-MD1 provides significant improvement in body-wide muscle function. This is associated with the protection of the hindlimb muscle from contraction-induced damage and the prevention of fibrosis deposition in the diaphragm muscle. Our work corroborates the observation that the administration of gene therapy in DMD is beneficial in preventing muscle fibrosis.

Published
2023
Full Text
View/download PDF

72. The incidence of surgical site infection following major lower limb amputation: A systematic review.

Author

Al‐Saadi, Nina, Al‐Hashimi, Khalid, Popplewell, Matthew, Fabre, Ismay, Gwilym, Brenig Llwyd, Hitchman, Louise, Chetter, Ian, Bosanquet, David C., and Wall, Michael L.

Subjects
LEG surgery, AMPUTATION, MEDICAL information storage & retrieval systems, SCIENTIFIC observation, PERIPHERAL vascular diseases, DESCRIPTIVE statistics, SYSTEMATIC reviews, DISEASES, MEDLINE, LEG amputation, SURGICAL site infections, DIABETES
Abstract

Surgical site infections (SSIs) following major lower limb amputation (MLLA) in vascular patients are a major source of morbidity. The objective of this systematic review was to determine the incidence of SSI following MLLA in vascular patients. This review was prospectively registered with the International Prospective Register of Systematic Reviews (CRD42023460645). Databases were searched without date restriction using a pre‐defined search strategy. The search identified 1427 articles. Four RCTs and 21 observational studies, reporting on 50 370 MLLAs, were included. Overall SSI incidence per MLLA incision was 7.2% (3628/50370). The incidence of SSI in patients undergoing through‐knee amputation (12.9%) and below‐knee amputation (7.5%) was higher than the incidence of SSI in patients undergoing above‐knee amputation, (3.9%), p < 0.001. The incidence of SSI in studies focusing on patients with peripheral arterial disease (PAD), diabetes or including patients with both was 8.9%, 6.8% and 7.2%, respectively. SSI is a common complication following MLLA in vascular patients. There is a higher incidence of SSI associated with more distal amputation levels. The reported SSI incidence is similar between patients with underlying PAD and diabetes. Further studies are needed to understand the exact incidence of SSI in vascular patients and the factors which influence this. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

73. Real‐world experience of axicabtagene ciloleucel, a CD19‐directed CAR T‐cell therapy, in the second‐line treatment of early relapsed or primary refractory large B‐cell lymphoma.

Author

Othman, Tamer, Baird, John H., Pak, Stacy, Mei, Matthew, Herrera, Alex F., Mansour, Joshua, Shouse, Geoffrey, Sahebi, Firoozeh, Spielberger, Ricardo, Cai, Ji‐Lian, Farol, Leonardo, Godfrey, James, Kallam, Avyakta, Phillips, Tycel, Popplewell, Leslie, Siddiqi, Tanya, Forman, Stephen, and Budde, Lihua E.

Subjects
SKIN cancer, T cells, INFORMED consent (Medical law)
Abstract

This article examines the use of axicabtagene ciloleucel (axi-cel), a CAR T-cell therapy, as a second-line treatment for large B-cell lymphoma (LBCL) in a real-world setting. The study analyzes data from patients who received axi-cel at a single center and evaluates various outcomes such as survival rates, response rates, and side effects. The results indicate that axi-cel is effective and well-tolerated, providing valuable insights for its use in clinical practice. However, larger studies with longer follow-up are needed to further validate its efficacy and practicality. [Extracted from the article]

Published
2024
Full Text
View/download PDF

74. Targeted Antisense Oligonucleotide-Mediated Skipping of Murine Postn Exon 17 Partially Addresses Fibrosis in D2. mdx Mice.

Author

Trundle, Jessica, Lu-Nguyen, Ngoc, Malerba, Alberto, and Popplewell, Linda

Subjects
TRANSFORMING growth factors-beta, PERIOSTIN, ALTERNATIVE RNA splicing, DUCHENNE muscular dystrophy, FIBROSIS, GRIP strength, INTEGRINS
Abstract

Periostin, a multifunctional 90 kDa protein, plays a pivotal role in the pathogenesis of fibrosis across various tissues, including skeletal muscle. It operates within the transforming growth factor beta 1 (Tgf-β1) signalling pathway and is upregulated in fibrotic tissue. Alternative splicing of Periostin's C-terminal region leads to six protein-coding isoforms. This study aimed to elucidate the contribution of the isoforms containing the amino acids encoded by exon 17 (e17+ Periostin) to skeletal muscle fibrosis and investigate the therapeutic potential of manipulating exon 17 splicing. We identified distinct structural differences between e17+ Periostin isoforms, affecting their interaction with key fibrotic proteins, including Tgf-β1 and integrin alpha V. In vitro mouse fibroblast experimentation confirmed the TGF-β1-induced upregulation of e17+ Periostin mRNA, mitigated by an antisense approach that induces the skipping of exon 17 of the Postn gene. Subsequent in vivo studies in the D2.mdx mouse model of Duchenne muscular dystrophy (DMD) demonstrated that our antisense treatment effectively reduced e17+ Periostin mRNA expression, which coincided with reduced full-length Periostin protein expression and collagen accumulation. The grip strength of the treated mice was rescued to the wild-type level. These results suggest a pivotal role of e17+ Periostin isoforms in the fibrotic pathology of skeletal muscle and highlight the potential of targeted exon skipping strategies as a promising therapeutic approach for mitigating fibrosis-associated complications. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

75. The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Author

Dominic Scaglioni, Francesco Catapano, Matthew Ellis, Silvia Torelli, Darren Chambers, Lucy Feng, Matthew Beck, Caroline Sewry, Mauro Monforte, Shawn Harriman, Erica Koenig, Jyoti Malhotra, Linda Popplewell, Michela Guglieri, Volker Straub, Eugenio Mercuri, Laurent Servais, Rahul Phadke, Jennifer Morgan, and Francesco Muntoni

Subjects
Dystrophin, Muscular dystrophy, Immunofluorescence, Genetic therapies, Golodirsen, Clinical trial, Neurology. Diseases of the nervous system, RC346-429
Abstract

Abstract During the last decade, multiple clinical trials for Duchenne muscular dystrophy (DMD) have focused on the induction of dystrophin expression using different strategies. Many of these trials have reported a clear increase in dystrophin protein following treatment. However, the low levels of the induced dystrophin protein have raised questions on its functionality. In our present study, using an unbiased, high-throughput digital image analysis platform, we assessed markers of regeneration and levels of dystrophin associated protein via immunofluorescent analysis of whole muscle sections in 25 DMD boys who received 48-weeks treatment with exon 53 skipping morpholino antisense oligonucleotide (PMO) golodirsen. We demonstrate that the de novo dystrophin induced by exon skipping with PMO golodirsen is capable of conferring a histological benefit in treated patients with an increase in dystrophin associated proteins at the dystrophin positive regions of the sarcolemma in post-treatment biopsies. Although 48 weeks treatment with golodirsen did not result in a significant change in the levels of fetal/developmental myosins for the entire cohort, there was a significant negative correlation between the amount of dystrophin and levels of regeneration observed in different biopsy samples. Our results provide, for the first time, evidence of functionality of induced dystrophin following successful therapeutic intervention in the human.

Published
2021
Full Text
View/download PDF

78. Real-World Tisagenlecleucel Outcomes in Richter-Transformed Chronic Lymphocytic Leukemia: A Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Author

Shadman, Mazyar, primary, Frigault, Matthew J., additional, Foley, Stephen Ronan, additional, Hill, Brian T., additional, Schofield, Grant, additional, Jacobson, Caron A., additional, Jaglowski, Samantha, additional, Locke, Frederick L., additional, Landsburg, Daniel J., additional, Ram, Ron, additional, Riedell, Peter A., additional, Shah, Gunjan L., additional, Popplewell, Leslie, additional, Tiwari, Ranjan, additional, Lim, Stephen, additional, Maier, Harald Jakob, additional, Majdan, Marta, additional, and Pasquini, Marcelo C., additional

Published
2024
Full Text
View/download PDF

79. Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel: Phase 2 Elara 3-Year Follow-up

Author

Schuster, Stephen J., primary, Fowler, Nathan H., additional, Dickinson, Michael, additional, Martinez-Lopez, Joaquin, additional, Kolstad, Arne, additional, Butler, Jason, additional, Ghosh, Monalisa, additional, Popplewell, Leslie, additional, Chavez, Julio C., additional, Bachy, Emmanuel, additional, Kato, Koji, additional, Harigae, Hideo, additional, Kersten, Marie José, additional, Andreadis, Charalambos, additional, Riedell, Peter A., additional, Ho, P Joy, additional, Pérez-Simón, José Antonio, additional, Chen, Andy I., additional, Nastoupil, Loretta J., additional, von Tresckow, Bastian, additional, Ferreri, Andres Jose Maria, additional, Teshima, Takanori, additional, Patten, Piers EM, additional, McGuirk, Joseph P., additional, Petzer, Andreas, additional, Offner, Fritz, additional, Viardot, Andreas, additional, Zinzani, Pier Luigi, additional, Malladi, Ram, additional, Zia, Aiesha, additional, Awasthi, Rakesh, additional, Paule, Ines, additional, Germano, Davide, additional, Ramos, Roberto, additional, Hsu, Pei, additional, Thieblemont, Catherine, additional, and Dreyling, Martin, additional

Published
2024
Full Text
View/download PDF

80. Durable Efficacy and Manageable Safety in Patients Age ≥75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting

Author

Landsburg, Daniel J., primary, Heim, Michael, additional, Moskop, Amy, additional, Foley, Stephen Ronan, additional, Hill, Brian T., additional, Schofield, Grant, additional, Jacobson, Caron A., additional, Jaglowski, Samantha, additional, Locke, Frederick L., additional, Ram, Ron, additional, Riedell, Peter A., additional, Shah, Gunjan L., additional, Popplewell, Leslie, additional, Tiwari, Ranjan, additional, Lim, Stephen, additional, Maier, Harald Jakob, additional, Majdan, Marta, additional, Pasquini, Marcelo C., additional, and Frigault, Matthew J., additional

Published
2024
Full Text
View/download PDF

84. A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study

Author

Kirschbaum, Mark H, Frankel, Paul, Synold, Timothy W, Xie, Zhiliang, Yen, Yun, Popplewell, Leslie, Chen, Robert, Aljitawi, Omar, Tuscano, Joseph M, Chan, Kenneth K, and Newman, Edward M

Subjects
Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Digestive Diseases, Clinical Research, Clinical Trials and Supportive Activities, Orphan Drug, Liver Disease, Hematology, Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Drug Monitoring, Female, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Oligodeoxyribonucleotides, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Ribonucleotide Reductases, Treatment Outcome, Acute leukemia, GTI-2040, intermittent infusion, phase I trial, pharmacodynamics, pharmacokinetics, ribonucleotide reductase, Immunology, Cardiovascular medicine and haematology
Abstract

We performed a phase I study of GTI-2040, an antisense oligonucleotide against ribonucleotide reductase mRNA, on a novel dosing schedule of days 1-4 and 15-18 by continuous infusion to examine efficacy and tolerability in patients with leukemia. A dose of 11 mg/kg/d was safely reached. Dose-limiting toxicities (DLTs) at the higher levels included elevated troponin I and liver function enzymes. There were no objective responses to GTI-2040 in this study; 7/24 patients were able to complete the predetermined three infusion cycles. Pharmacokinetic and pharmacodynamic studies were performed, indicating a trend towards increasing intracellular drug levels and decreasing RRM2 gene expression with increasing doses. This dose schedule may be considered if appropriate combinations are identified in preclinical studies.

Published
2016

86. Mutation-Directed Therapeutics for Neurofibromatosis Type I

Author

Andre Leier, David M. Bedwell, Ann T. Chen, George Dickson, Kim M. Keeling, Robert A. Kesterson, Bruce R. Korf, Tatiana T. Marquez Lago, Ulrich F. Müller, Linda Popplewell, Jiangbing Zhou, and Deeann Wallis

Subjects
Therapeutics. Pharmacology, RM1-950
Abstract

Significant advances in biotechnology have led to the development of a number of different mutation-directed therapies. Some of these techniques have matured to a level that has allowed testing in clinical trials, but few have made it to approval by drug-regulatory bodies for the treatment of specific diseases. While there are still various hurdles to be overcome, recent success stories have proven the potential power of mutation-directed therapies and have fueled the hope of finding therapeutics for other genetic disorders. In this review, we summarize the state-of-the-art of various therapeutic approaches and assess their applicability to the genetic disorder neurofibromatosis type I (NF1). NF1 is caused by the loss of function of neurofibromin, a tumor suppressor and downregulator of the Ras signaling pathway. The condition is characterized by a variety of phenotypes and includes symptoms such as skin spots, nervous system tumors, skeletal dysplasia, and others. Hence, depending on the patient, therapeutics may need to target different tissues and cell types. While we also discuss the delivery of therapeutics, in particular via viral vectors and nanoparticles, our main focus is on therapeutic techniques that reconstitute functional neurofibromin, most notably cDNA replacement, CRISPR-based DNA repair, RNA repair, antisense oligonucleotide therapeutics including exon skipping, and nonsense suppression.

Published
2020
Full Text
View/download PDF

87. The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Author

Scaglioni, Dominic, Catapano, Francesco, Ellis, Matthew, Torelli, Silvia, Chambers, Darren, Feng, Lucy, Beck, Matthew, Sewry, Caroline, Monforte, Mauro, Harriman, Shawn, Koenig, Erica, Malhotra, Jyoti, Popplewell, Linda, Guglieri, Michela, Straub, Volker, Mercuri, Eugenio, Servais, Laurent, Phadke, Rahul, Morgan, Jennifer, and Muntoni, Francesco

Published
2021
Full Text
View/download PDF

88. RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathways

Author

Gudiño, Victoria, Pohl, Sebastian Öther-Gee, Billard, Caroline V., Cammareri, Patrizia, Bolado, Alfonso, Aitken, Stuart, Stevenson, David, Hall, Adam E., Agostino, Mark, Cassidy, John, Nixon, Colin, von Kriegsheim, Alex, Freile, Paz, Popplewell, Linda, Dickson, George, Murphy, Laura, Wheeler, Ann, Dunlop, Malcolm, Din, Farhat, Strathdee, Douglas, Sansom, Owen J., and Myant, Kevin B.

Published
2021
Full Text
View/download PDF

89. Stealing Winston Churchill.

Author

POPPLEWELL, BRETT

Subjects
ART thefts, FORGERY
Abstract

The article explores the theft of a valuable portrait of Winston Churchill, known as The Roaring Lion, highlighting three key aspects: the initial discovery of the forgery at the Fairmont Château Laurier, the police investigation into the art heist, and the portrait's historical significance.

Published
2024

93. DOCTOR FENTANYL

Author

Popplewell, Brett

Subjects
Family medicine, Personal loans, General interest, Home and garden, Travel, recreation and leisure
Abstract

George Otto was a respected family physician with a bustling clinic in the northwest corner of the city. But he had a secret: after hours, he was running a booming [...]

Published
2021

95. Respiratory Medications in Infants

Author

Alexander, Barbara, Gratton, Tari, Grigsby, Cathy, Koch, Beth, Thornton, Kelly, Bates, Pamela, Cleveland, Claudia, Hoffmann, Julie, Linneman, Laura, Sicard-Su, Jayne, Simpson, Gina, Asselin, Jeanette M., Balan, Samantha, Burson, Katrina, Chapin, Cheryl, Josiah-Davis, Erna, Garcia, Carmen, Horneman, Hart, Hinojosa, Rick, Johnson, Christopher, Kelley, Susan, Knowles, Karin L., Lillie, M. Layne, Martin, Karen, Martin, Sarah, Arldt-McAlister, Julie, McDavid, Georgia E., Pacello, Lori, Rodgers, Shawna, Sperry, Daniel K., Beller, Amy B., Hunt, Mark O’, Rogers, Theresa J., Settles, Odessa L., Steele, Steven, Wadley, Sharon, Castiglione, Shannon, Horan, Aimee, Maffet, Deanna, O'Donnell, Jane, Sacilowski, Michael, Scalise, Tanya, Werner, Elizabeth, Zayac, Jason, Huyck, Heidie, Lunger, Valerie, Bordeaux, Kim, Brown, Pam, Epping, Julia, Flattery-Walsh, Lisa, Germuga, Donna, Jenks, Nancy, Platt, Mary, Popplewell, Eileen, Prentice, Sandra, Ciccio, Kim, Clem, Charles, Gunn, Susan, Jewett, Lauren, Blanco, Maria, Cifelli, Denise, DeMauro, Sara, Fernando, Melissa, Tierney, Ann, Taussig, Lynn M., Blaisdell, Carol J., Chougnet, Claire, Hardie, William, Jobe, Alan H., McDowell, Karen, Ferkol, Thomas, Hamvas, Aaron, Holland, Mark R., Kemp, James, Levy, Philip T., Tarr, Phillip, Singh, Gautam K., Warner, Barbara, Ballard, Philip L., Ballard, Roberta A., Durand, David J., Eichenwald, Eric C., Khan, Amir M., Lusk, Leslie, Merrill, Jeffrey D., Nielson, Dennis W., Rogers, Elizabeth E., Aschner, Judy, Fike, Candice, Guthrie, Scott, Hartert, Tina, Maitre, Nathalie, Summar, Marshall, Kumar, Vasanth, Mariani, Tom, Pryhuber, Gloria, Ren, Clement, Reynolds, Anne Marie, Scheible, Kristin, Stevens, Timothy, Cotten, C. Michael, Fisher, Kim, Sharp, Jack, Voynow, Judith A., Davis, Stephanie, Ellenberg, Jonas, Feng, Rui, Panitch, Howard, Schmidt, Barbara, Ryan, Rita M., Keller, Roberta L., Poindexter, Brenda B., D'Angio, Carl T., Shaw, Pamela A., Bellamy, Scarlett L., Moore, Paul E., McPherson, Christopher, and Greenberg, James M.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results